FDA Approves Sexual Desire Drug for Postmenopausal Women

By News Health
2 months Ago

(MedPage Today) — The FDA expanded the approval of flibanserin (Addyi), a drug that treats low sexual desire in women, to now include some postmenopausal women, drugmaker Sprout Pharmaceuticals announced on Monday.
Flibanserin is a mixed 5-HT1A…

Source link : https://www.medpagetoday.com/obgyn/menopause/119031

Author :

Publish date : 2025-12-15 22:41:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

Autism Experts Concerned Over Advisory Panel Overhaul

Clinicians Mourn Alex Pretti; RN's Snowy Commute; Diet Soda Misconceptions

GLP-1 Drugs and Liver Complications; Tracking Endoscopists' Eyes; Peppermint for IBS

Cut Years Off College, Not Medical School

New Videos Show Alex Pretti Scuffle With Federal Officers 11 Days Before His Death

FDA OKs More Eye Drops That Can Replace Reading Glasses